Review Article| Volume 50, ISSUE 1, P121-136, March 2023

Medications for Managing Preexisting and Gestational Diabetes in Pregnancy


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Obstetrics and Gynecology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Deputy N.P.
        • Kim S.Y.
        • Conrey E.J.
        • et al.
        Prevalence and Changes in Preexisting Diabetes and Gestational Diabetes Among Women Who Had a Live Birth - United States, 2012-2016.
        MMWR Morb Mortal Wkly Rep. 2018; 67: 1201-1207
        • Coustan D.R.
        • Lowe L.P.
        • Metzger B.E.
        • et al.
        The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus.
        Am J Obstet Gynecol. 2010; 202: 654.e1-654.e6
      1. SMFM Statement: Pharmacological treatment of gestational diabetes.
        Am J Obstet Gynecol. 2018; 218: B2-B4
        • Alvarez-Silvares E.
        • Bermúdez-González M.
        • Vilouta-Romero M.
        • et al.
        Prediction of insulin therapy in women with gestational diabetes: a systematic review and meta-analysis of observational studies.
        J Perinat Med. 2022; 50: 608-619
        • Caissutti C.
        • Saccone G.
        • Khalifeh A.
        • et al.
        Which criteria should be used for starting pharmacologic therapy for management of gestational diabetes in pregnancy? Evidence from randomized controlled trials.
        J Matern Fetal Neonatal Med. 2019; 32: 2905-2914
        • Langer O.
        • Conway D.L.
        • Berkus M.D.
        • et al.
        A comparison of glyburide and insulin in women with gestational diabetes mellitus.
        N Engl J Med. 2000; 343: 1134-1138
        • Balsells M.
        • García-Patterson A.
        • Solà I.
        • et al.
        Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis.
        BMJ. 2015; 350: h102
        • Tripathi R.
        • Tyagi S.
        • Goel V.
        Metformin in gestational diabetes mellitus.
        Indian J Med Res. 2017; 145: 588-591
        • Feig D.S.
        • Donovan L.E.
        • Corcoy R.
        • et al.
        Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
        Lancet. 2017; 390: 2347-2359
        • Santos L.L.
        • Santos J.L.
        • Barbosa L.T.
        • et al.
        Effectiveness of Insulin Analogs Compared with Human Insulins in Pregnant Women with Diabetes Mellitus: Systematic Review and Meta-analysis.
        Rev Bras Ginecol Obstet. 2019; 41 (Efetividade dos análogos da insulina comparados às insulinas humanas em gestantes com diabetes mellitus: Revisão sistemática com metanálise): 104-115
        • Mathiesen E.R.
        • Kinsley B.
        • Amiel S.A.
        • et al.
        Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women.
        Diabetes Care. 2007; 30: 771-776
        • Zuckerwise L.C.
        • Werner E.F.
        • Pettker C.M.
        • et al.
        Pregestational diabetes with extreme insulin resistance: use of U-500 insulin in pregnancy.
        Obstet Gynecol. 2012; 120: 439-442
        • Herrera K.M.
        • Rosenn B.M.
        • Foroutan J.
        • et al.
        Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes.
        Am J Obstet Gynecol. 2015; 213: 426.e1-426.e7
        • Pollex E.
        • Moretti M.E.
        • Koren G.
        • et al.
        Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis.
        Ann Pharmacother. 2011; 45: 9-16
        • Hiranput S.
        • Ahmed S.H.
        • Macaulay D.
        • et al.
        Successful outcomes with insulin degludec in pregnancy: a case series.
        Diabetes Ther. 2019; 10: 283-289
        • Barbour L.A.
        • Scifres C.
        • Valent A.M.
        • et al.
        A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes.
        Am J Obstet Gynecol. 2018; 219: 367.e1-367.e7
        • Feig D.S.
        • Donovan L.E.
        • Zinman B.
        • et al.
        Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
        Lancet Diabetes Endocrinol. 2020; 8: 834-844
        • Rowan J.A.
        • Hague W.M.
        • Gao W.
        • et al.
        Metformin versus insulin for the treatment of gestational diabetes.
        N Engl J Med. 2008; 358: 2003-2015
        • Rø T.B.
        • Ludvigsen H.V.
        • Carlsen S.M.
        • et al.
        Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero.
        Scand J Clin Lab Invest. 2012; 72: 570-575
        • Rowan J.A.
        • Rush E.C.
        • Plank L.D.
        • et al.
        Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age.
        BMJ Open Diabetes Res Care. 2018; 6: e000456
        • Tarry-Adkins J.L.
        • Aiken C.E.
        • Ozanne S.E.
        Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis.
        PLoS Med. 2019; 16: e1002848
        • Eyal S.
        • Easterling T.R.
        • Carr D.
        • et al.
        Pharmacokinetics of metformin during pregnancy.
        Drug Metab Dispos. 2010; 38: 833-840
        • Gardiner S.J.
        • Kirkpatrick C.M.
        • Begg E.J.
        • et al.
        Transfer of metformin into human milk.
        Clin Pharmacol Ther. 2003; 73: 71-77
        • Hale T.W.
        • Kristensen J.H.
        • Hackett L.P.
        • et al.
        Transfer of metformin into human milk.
        Diabetologia. 2002; 45: 1509-1514
        • Briggs G.G.
        • Ambrose P.J.
        • Nageotte M.P.
        • et al.
        Excretion of metformin into breast milk and the effect on nursing infants.
        Obstet Gynecol. 2005; 105: 1437-1441
        • He K.
        • Guo Q.
        • Ge J.
        • et al.
        The efficacy and safety of metformin alone or as an add-on therapy to insulin in pregnancy with GDM or T2DM: A systematic review and meta-analysis of 21 randomized controlled trials.
        J Clin Pharm Ther. 2022; 47: 168-177
        • Gui J.
        • Liu Q.
        • Feng L.
        Metformin vs insulin in the management of gestational diabetes: a meta-analysis.
        PLoS One. 2013; 8: e64585
        • Zeller M.
        • Danchin N.
        • Simon D.
        • et al.
        Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction.
        J Clin Endocrinol Metab. 2010; 95: 4993-5002
        • Liang H.L.
        • Ma S.J.
        • Xiao Y.N.
        • et al.
        Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis.
        Medicine (Baltimore). 2017; 96: e7939
        • Caritis S.N.
        • Hebert M.F.
        A pharmacologic approach to the use of glyburide in pregnancy.
        Obstet Gynecol. 2013; 121: 1309-1312
        • Rochon M.
        • Rand L.
        • Roth L.
        • et al.
        Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes.
        Am J Obstet Gynecol. 2006; 195: 1090-1094
        • Anjalakshi C.
        • Balaji V.
        • Balaji M.S.
        • et al.
        A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women.
        Diabetes Res Clin Pract. 2007; 76: 474-475
        • Silva J.C.
        • Pacheco C.
        • Bizato J.
        • et al.
        Metformin compared with glyburide for the management of gestational diabetes.
        Int J Gynaecol Obstet. 2010; 111: 37-40
        • Oliveira M.M.
        • Andrade K.F.O.
        • Lima G.H.S.
        • et al.
        Metformin versus glyburide in treatment and control of gestational diabetes mellitus: a systematic review with meta-analysis.
        Einstein (Sao Paulo). 2022; 20: eRW6155
        • Song R.
        • Chen L.
        • Chen Y.
        • et al.
        Comparison of glyburide and insulin in the management of gestational diabetes: a meta-analysis.
        PLoS One. 2017; 12: e0182488
        • Moretti M.E.
        • Rezvani M.
        • Koren G.
        Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes.
        Ann Pharmacother. 2008; 42: 483-490
        • Hedderson M.M.
        • Badon S.E.
        • Pimentel N.
        • et al.
        Association of Glyburide and Subcutaneous Insulin With Perinatal Complications Among Women With Gestational Diabetes.
        JAMA Netw Open. 2022; 5: e225026
        • Kahn B.F.
        • Davies J.K.
        • Lynch A.M.
        • et al.
        Predictors of glyburide failure in the treatment of gestational diabetes.
        Obstet Gynecol. 2006; 107: 1303-1309
        • Cheng Y.W.
        • Chung J.H.
        • Block-Kurbisch I.
        • et al.
        Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes.
        J Matern Fetal Neonatal Med. 2012; 25: 379-384
        • Palatnik A.
        • Harrison R.K.
        • Thakkar M.Y.
        • et al.
        Correlates of Insulin Selection as a First-Line Pharmacological Treatment for Gestational Diabetes.
        Am J Perinatol. 2022; 39: 8-15
        • McIver L.A.
        • Preuss C.V.
        • Tripp J.
        Acarbose. StatPearls.
        StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC., Treasure Island, FL2022
        • Jayasingh S.
        • Sr
        • Nanda S.
        • et al.
        Comparison of fetomaternal outcomes in patients with gestational diabetes mellitus treated with insulin versus acarbose: results of a prospective, open label, controlled study.
        Cureus. 2020; 12: e12283
        • Wang X.
        • Liu W.
        • Chen H.
        • et al.
        Comparison of insulin, metformin, and glyburide on perinatal complications of gestational diabetes mellitus: a systematic review and meta-analysis.
        Gynecol Obstet Invest. 2021; 86: 218-230
        • Murphy H.R.
        • Elleri D.
        • Allen J.M.
        • et al.
        Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy.
        Diabetologia. 2012; 55: 282-293